Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

1. Rodrigues, G.
2. Oberije, C.
3. Senan, S.
4. Tsujino, K.
5. Wiersma, T.
6. Moreno-Jimenez, M.
7. Kim, T.H.
8. Marks, L.B.
9. Rengan, R.
10. De Petris, L.
11. Ramella, S.
12. DeRuyck, K.
13. Rodriguez De Dios, N.
14. Warner, A.
15. Bradley, J.D.
16. Palma, D.A.